Are randomized trials obsolete or more important than ever in the genomic era?

Genome Medicine: April 18, 2013

The genomic era has raised the possibility of major changes in the design, conduct, and even the existence of randomized trials as we know them [1-3]. Randomized trials are often seen as a slow, laborious, expensive, and difficult step in the translational process and are associated with a high attrition rate for drugs. Read more